p-Coumaric Acid Attenuates Cardiac Fibrosis via AMPK-Associated Paracrine Crosstalk Between Fibroblasts and Endothelial Cells

Diabetic cardiomyopathy (DCM) is characterized by cardiac fibrosis and adverse remodeling, for which effective targeted therapies remain lacking. Previously, p-coumaric acid (PCA), a phenolic compound found in Phoenix dactylifera and Beta vulgaris, was demonstrated by us as having antihyperglycemic and antifibrotic potential, but its mechanism of action and effects on cardiac cell crosstalk remained unexplored. Recently, we investigated the possibility that antifibrotic effects of PCA on cardiac fibroblasts might be observed through AMPK-associated regulation of the PPAR-α/MAPK pathway and possible paracrine effects on cardiomyocytes and endothelial cells. For this purpose, human cardiac fibroblasts (HCFs) were cultured under glycemic and fibrotic conditions with or without PCA treatment, and cells were exposed to compound C to block AMPK. Afterwards, conditioned media was collected from these cells and applied to human umbilical vein endothelial cells (HUVECs) and AC16 cardiomyocytes. Our results showed that PCA significantly decreased the gene and protein expression levels of CTGF and α-SMA in HCFs, confirming its antifibrotic effects even in the presence of compound C (a potent AMPK inhibitor). Mechanistically, PCA partly modulated AMPK levels, which further upregulated levels of PPAR-α and downregulated MAPK levels. Moreover, conditioned media-treated HUVECs showed a significantly improved p-eNOS/e-NOS ratio, a molecular change associated with improved endothelial function through paracrine effects. In AC16 cardiomyocytes, there was significant reduction in troponin levels while AMPK and PPAR-α were upregulated. These findings demonstrated that PCA exerts its antifibrotic effects partly through the AMPK-associated pathway and also confers protective paracrine effects on endothelial cells and cardiomyocytes, suggesting its significant potential in DCM-associated cardiac remodeling.

Authors

Institutions

Publication Details

Journal
Cells
Published
2026-11-16
DOI
https://doi.org/10.3390/cells15222089
Primary Topic
Cardiac Fibrosis and Remodeling
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

p-Coumaric Acid Attenuates Cardiac Fibrosis via AMPK-Associated Paracrine Crosstalk Between Fibroblasts and Endothelial Cells

Laaraib Nawaz, Hussam Daghistani, Shahzad Irfan, David Grieve et al.
1 links
Cells
Cardiac Fibrosis and Remodeling
article

p-Coumaric Acid Attenuates Cardiac Fibrosis via AMPK-Associated Paracrine Crosstalk Between Fibroblasts and Endothelial Cells

Laaraib Nawaz, Hussam Daghistani, Shahzad Irfan, David Grieve, Kevin S. Edgar, Mohammed H. Alsaggaf
article en

Abstract

Diabetic cardiomyopathy (DCM) is characterized by cardiac fibrosis and adverse remodeling, for which effective targeted therapies remain lacking. Previously, p-coumaric acid (PCA), a phenolic compound found in Phoenix dactylifera and Beta vulgaris, was demonstrated by us as having antihyperglycemic and antifibrotic potential, but its mechanism of action and effects on cardiac cell crosstalk remained unexplored. Recently, we investigated the possibility that antifibrotic effects of PCA on cardiac fibroblasts might be observed through AMPK-associated regulation of the PPAR-α/MAPK pathway and possible paracrine effects on cardiomyocytes and endothelial cells. For this purpose, human cardiac fibroblasts (HCFs) were cultured under glycemic and fibrotic conditions with or without PCA treatment, and cells were exposed to compound C to block AMPK. Afterwards, conditioned media was collected from these cells and applied to human umbilical vein endothelial cells (HUVECs) and AC16 cardiomyocytes. Our results showed that PCA significantly decreased the gene and protein expression levels of CTGF and α-SMA in HCFs, confirming its antifibrotic effects even in the presence of compound C (a potent AMPK inhibitor). Mechanistically, PCA partly modulated AMPK levels, which further upregulated levels of PPAR-α and downregulated MAPK levels. Moreover, conditioned media-treated HUVECs showed a significantly improved p-eNOS/e-NOS ratio, a molecular change associated with improved endothelial function through paracrine effects. In AC16 cardiomyocytes, there was significant reduction in troponin levels while AMPK and PPAR-α were upregulated. These findings demonstrated that PCA exerts its antifibrotic effects partly through the AMPK-associated pathway and also confers protective paracrine effects on endothelial cells and cardiomyocytes, suggesting its significant potential in DCM-associated cardiac remodeling.

CellsVol. 15(22)
Queen's University Belfast (GB), University of Lahore (PK), King Abdulaziz University (SA), Government College University, Faisalabad (PK)
Good health and well-being
Cardiac Fibrosis and Remodeling
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon